Document is current
Any future updates will be listed below
-
Authors
Siebert, Johan N. https://orcid.org/0000-0002-2871-3382
Bloudeau, Laurie
Ehrler, Frédéric
Combescure, Christophe
Haddad, Kevin
Hugon, Florence
Suppan, Laurent
Rodieux, Frédérique
Lovis, Christian
Gervaix, Alain
Manzano, Sergio
-
Funding
Funding for this research was provided by:
Swiss National Science Foundation (32003B_182374)
- License Information
-
More Information
Article History
Received: 30 April 2019
Accepted: 13 September 2019
First Online: 20 November 2019
Ethics approval and consent to participate
: According to Art. 47 paragraphs 2–4 of the Swiss Federal Act on Research involving Human Beings (Human Research Act, status as of 1 January 2014), and Swiss Ethics Committees on research involving humans (Swissethics), multicenter studies that are being conducted in several cantons/trial centers in Switzerland should not have to be reviewed in full by every cantonal ethics committee, but only from the lead ethics committee which is responsible at the site of activity of the project coordinator. This trial protocol version 1.0 received a declaration of no objection by the Geneva Cantonal Ethics Committee on 29 March 2018, as the purpose of the study will be to examine the effect of the intervention on health care providers. The trial will be conducted according to the principles of the Declaration of Helsinki [] and Good Clinical Practice guidelines []. Written informed consent will be obtained from all participants.
: Not applicable.
: Geneva University Hospitals are the owners of the app PedAMINES. The app is available on the Google Play Store and the App Store (Apple). All authors declare no competing interests.
